The Angiotensin II Receptor Blockers Market is expected to register a CAGR of 7.85% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
This Angiotensin II Receptor Blockers (ARBs) Market report combines comprehensive analysis of the global ARBs market size, growth drivers, challenges, trends, competitive landscape, and future outlook. ARBs are a type of drugs used in treating high blood pressure and other cardiovascular disorders. The report explores factors that drive market growth in the form of increased incidence of cardiovascular diseases, aging population, and increased healthcare expenditure. On top of this, the report discusses the challenges faced by the market, such as generic competition, strict regulatory requirements, and potential adverse effects associated with ARBs. The competitive landscape analysis is also given, with profiles of leading players in the market and their best strategies to win shares. Finally, the report gives out insights into the future outlook of the ARBs market, with potential growth opportunities and emerging trends.
Purpose of the ReportThe report Angiotensin II Receptor Blockers Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Angiotensin II Receptor Blockers Market Segmentation
Type- Azilsartan
- Candesartan
- Eprosartan
- Irbesartan
- Losartan
- Olmesartan
- Telmisartan
- Valsartan
- Hypertension
- Cardiovascular Risks
- Kidney Failure In Diabetes
- Chronic Kidney Diseases
Strategic Insights
Angiotensin II Receptor Blockers Market Growth Drivers- Increasing Incidences of Cardiovascular Diseases: Significant growth in the incidence of cardiovascular diseases, including hypertension, heart failure, and chronic kidney disease, is propelling the Angiotensin II Receptor Blockers (ARBs) market. An aging world is finding an increasing incidence of such conditions, which further fuels the push for effective management.
- Increasing Awareness of cardiovascular health: Increasing awareness of cardiovascular health and the necessity of timely diagnosis and treatment are further adding to this market requirement.
- Advancement in Drug Delivery: Advanced drug delivery systems like extended-release formulations improve the patient compliance with efficacy, thus increasing the market demand. Growth in healthcare expenditures and healthcare infrastructure in developing countries creates further opportunities for the ARBs market.
- Combination Therapies: The point of emphasis on combination therapies in the ARBs market is that ARBs are administered combined with other drugs for enhanced therapeutic efficacy. It is most appropriate for patients with complex cardiovascular disorders.
- New drug delivery systems evolve: extended-release formulations and targeted drug delivery will eventually improve drug compliance and the effectiveness of treatment in the future.
- Tailored Treatments: Other factors include new precision medicine-tailoring treatment to individual patient characteristics, a trend likely to increase demand for ARBs. As our understanding of the fundamental mechanisms of cardiovascular diseases advances, there is, thus, scope for developing next-generation ARBs with better therapeutic profiles. The high incidence of cardiovascular diseases in emerging markets holds significant growth opportunities for the ARBs market.
- Product Innovation: There lies a substantial opportunity for pharmaceutical companies to develop newer ARBs having improved efficacy, safety, and tolerability profiles. Moreover, the expanding healthcare infrastructure in emerging markets and growing disposable incomes are creating new growth avenues in the ARBs market.
- Growth of Generic ARBs: As several ARBs have moved off-patent, the rise of generic versions is lowering the cost of treatment, and improving access for a larger population. Generic ARBs are expected to capture a significant share of the market, especially in developing regions where cost-effective options are in high demand.
- Rising Hypertension Prevalence: Rising prevalence of hypertension and related cardiovascular diseases creates significant growth opportunities for the ARBs market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Angiotensin II Receptor Blockers Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Angiotensin II Receptor Blockers Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The leading players of the market are: AstraZeneca, Daichii Sankyo, Novartis, Abbvie, Lupin, Takeda, Zydus Cadila, Sun Pharmaceutical, Abbott Laboratories, ALEMBIC PHARMS LTD., MYLAN
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Combination therapies, where ARBs are used in conjunction with other drugs, are rapidly gaining prominence for better therapeutic outcomes. Extended-release formulations and targeted drug delivery, among others, will help improve patient compliance and efficacy. Precision medicine-tailoring treatment according to individual patient characteristics-will also drive demand for ARBs. The development of next-generation ARBs with improved profiles is another key trend. Finally, the increasing prevalence of cardiovascular diseases in emerging markets gives more growth opportunities.
Angiotensin II Receptor Blockers Market is expected to grow at a CAGR of 7.85% between 2023-2031
Drivers in the market for Angiotensin II Receptor Blockers include growing cardiovascular diseases such as hypertension, heart failure, and chronic kidney disease, among others. An aging population along with increased healthcare expenditure along with cardiocentric health awareness also fosters growth in the market. Advancements in drug delivery systems, combination therapies, and the development of novel ARBs with improved efficacy and safety profiles are further propelling the market forward. Several key trends define the future of the Angiotensin II Receptor Blockers (ARBs) market.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Angiotensin II Receptor Blockers Market - By Type
1.3.2 Angiotensin II Receptor Blockers Market - By Application
1.3.3 Angiotensin II Receptor Blockers Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANGIOTENSIN II RECEPTOR BLOCKERS - GLOBAL MARKET OVERVIEW
6.2. ANGIOTENSIN II RECEPTOR BLOCKERS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. AZILSARTAN
7.3.1. Overview
7.3.2. Azilsartan Market Forecast and Analysis
7.4. CANDESARTAN
7.4.1. Overview
7.4.2. Candesartan Market Forecast and Analysis
7.5. EPROSARTAN
7.5.1. Overview
7.5.2. Eprosartan Market Forecast and Analysis
7.6. IRBESARTAN
7.6.1. Overview
7.6.2. Irbesartan Market Forecast and Analysis
7.7. LOSARTAN
7.7.1. Overview
7.7.2. Losartan Market Forecast and Analysis
7.8. OLMESARTAN
7.8.1. Overview
7.8.2. Olmesartan Market Forecast and Analysis
7.9. TELMISARTAN
7.9.1. Overview
7.9.2. Telmisartan Market Forecast and Analysis
7.10. VALSARTAN
7.10.1. Overview
7.10.2. Valsartan Market Forecast and Analysis
8. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HYPERTENSION
8.3.1. Overview
8.3.2. Hypertension Market Forecast and Analysis
8.4. CARDIOVASCULAR RISKS
8.4.1. Overview
8.4.2. Cardiovascular Risks Market Forecast and Analysis
8.5. KIDNEY FAILURE IN DIABETES
8.5.1. Overview
8.5.2. Kidney Failure In Diabetes Market Forecast and Analysis
8.6. CHRONIC KIDNEY DISEASES
8.6.1. Overview
8.6.2. Chronic Kidney Diseases Market Forecast and Analysis
9. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Angiotensin II Receptor Blockers Market Overview
9.1.2 North America Angiotensin II Receptor Blockers Market Forecasts and Analysis
9.1.3 North America Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Type
9.1.4 North America Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Application
9.1.5 North America Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Countries
9.1.5.1 United States Angiotensin II Receptor Blockers Market
9.1.5.1.1 United States Angiotensin II Receptor Blockers Market by Type
9.1.5.1.2 United States Angiotensin II Receptor Blockers Market by Application
9.1.5.2 Canada Angiotensin II Receptor Blockers Market
9.1.5.2.1 Canada Angiotensin II Receptor Blockers Market by Type
9.1.5.2.2 Canada Angiotensin II Receptor Blockers Market by Application
9.1.5.3 Mexico Angiotensin II Receptor Blockers Market
9.1.5.3.1 Mexico Angiotensin II Receptor Blockers Market by Type
9.1.5.3.2 Mexico Angiotensin II Receptor Blockers Market by Application
9.2. EUROPE
9.2.1 Europe Angiotensin II Receptor Blockers Market Overview
9.2.2 Europe Angiotensin II Receptor Blockers Market Forecasts and Analysis
9.2.3 Europe Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Type
9.2.4 Europe Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Application
9.2.5 Europe Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Angiotensin II Receptor Blockers Market
9.2.5.1.1 Germany Angiotensin II Receptor Blockers Market by Type
9.2.5.1.2 Germany Angiotensin II Receptor Blockers Market by Application
9.2.5.2 France Angiotensin II Receptor Blockers Market
9.2.5.2.1 France Angiotensin II Receptor Blockers Market by Type
9.2.5.2.2 France Angiotensin II Receptor Blockers Market by Application
9.2.5.3 Italy Angiotensin II Receptor Blockers Market
9.2.5.3.1 Italy Angiotensin II Receptor Blockers Market by Type
9.2.5.3.2 Italy Angiotensin II Receptor Blockers Market by Application
9.2.5.4 Spain Angiotensin II Receptor Blockers Market
9.2.5.4.1 Spain Angiotensin II Receptor Blockers Market by Type
9.2.5.4.2 Spain Angiotensin II Receptor Blockers Market by Application
9.2.5.5 United Kingdom Angiotensin II Receptor Blockers Market
9.2.5.5.1 United Kingdom Angiotensin II Receptor Blockers Market by Type
9.2.5.5.2 United Kingdom Angiotensin II Receptor Blockers Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Angiotensin II Receptor Blockers Market Overview
9.3.2 Asia-Pacific Angiotensin II Receptor Blockers Market Forecasts and Analysis
9.3.3 Asia-Pacific Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Angiotensin II Receptor Blockers Market
9.3.5.1.1 Australia Angiotensin II Receptor Blockers Market by Type
9.3.5.1.2 Australia Angiotensin II Receptor Blockers Market by Application
9.3.5.2 China Angiotensin II Receptor Blockers Market
9.3.5.2.1 China Angiotensin II Receptor Blockers Market by Type
9.3.5.2.2 China Angiotensin II Receptor Blockers Market by Application
9.3.5.3 India Angiotensin II Receptor Blockers Market
9.3.5.3.1 India Angiotensin II Receptor Blockers Market by Type
9.3.5.3.2 India Angiotensin II Receptor Blockers Market by Application
9.3.5.4 Japan Angiotensin II Receptor Blockers Market
9.3.5.4.1 Japan Angiotensin II Receptor Blockers Market by Type
9.3.5.4.2 Japan Angiotensin II Receptor Blockers Market by Application
9.3.5.5 South Korea Angiotensin II Receptor Blockers Market
9.3.5.5.1 South Korea Angiotensin II Receptor Blockers Market by Type
9.3.5.5.2 South Korea Angiotensin II Receptor Blockers Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Angiotensin II Receptor Blockers Market Overview
9.4.2 Middle East and Africa Angiotensin II Receptor Blockers Market Forecasts and Analysis
9.4.3 Middle East and Africa Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Angiotensin II Receptor Blockers Market
9.4.5.1.1 South Africa Angiotensin II Receptor Blockers Market by Type
9.4.5.1.2 South Africa Angiotensin II Receptor Blockers Market by Application
9.4.5.2 Saudi Arabia Angiotensin II Receptor Blockers Market
9.4.5.2.1 Saudi Arabia Angiotensin II Receptor Blockers Market by Type
9.4.5.2.2 Saudi Arabia Angiotensin II Receptor Blockers Market by Application
9.4.5.3 U.A.E Angiotensin II Receptor Blockers Market
9.4.5.3.1 U.A.E Angiotensin II Receptor Blockers Market by Type
9.4.5.3.2 U.A.E Angiotensin II Receptor Blockers Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Angiotensin II Receptor Blockers Market Overview
9.5.2 South and Central America Angiotensin II Receptor Blockers Market Forecasts and Analysis
9.5.3 South and Central America Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Type
9.5.4 South and Central America Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Application
9.5.5 South and Central America Angiotensin II Receptor Blockers Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Angiotensin II Receptor Blockers Market
9.5.5.1.1 Brazil Angiotensin II Receptor Blockers Market by Type
9.5.5.1.2 Brazil Angiotensin II Receptor Blockers Market by Application
9.5.5.2 Argentina Angiotensin II Receptor Blockers Market
9.5.5.2.1 Argentina Angiotensin II Receptor Blockers Market by Type
9.5.5.2.2 Argentina Angiotensin II Receptor Blockers Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANGIOTENSIN II RECEPTOR BLOCKERS MARKET, KEY COMPANY PROFILES
11.1. ASTRAZENECA
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. DAICHII SANKYO
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NOVARTIS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ABBVIE
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LUPIN
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. TAKEDA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ZYDUS CADILA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SUN PHARMACEUTICAL
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ABBOTT LABORATORIES
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ALEMBIC PHARMS LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
11.11. MYLAN
11.11.1. Key Facts
11.11.2. Business Description
11.11.3. Products and Services
11.11.4. Financial Overview
11.11.5. SWOT Analysis
11.11.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. AstraZeneca
2. Daichii Sankyo
3. Novartis
4. Abbvie
5. Lupin
6. Takeda
7. Zydus Cadila
8. Sun Pharmaceutical
9. Abbott Laboratories
10. ALEMBIC PHARMS LTD.
11. MYLAN
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For